Does aspirin affect outcome in vascular dementia? A retrospective case-notes analysis

International Journal of Geriatric Psychiatry

Volumn 18, Issue 5, 2003, Pages 425-431

  Devine, Michael Ellis ^a   Rands, G ^b  

^a Drayton Community Care Centre   (United Kingdom)

^b WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Aspirin; Dementia, vascular; Retrospective studies; Survival analysis; Treatment outcome

Indexed keywords

ACETYLSALICYLIC ACID;

AGED; ARTICLE; BEHAVIOR; CAREGIVER; CASE STUDY; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DRUG EFFECT; FEMALE; GENERAL PRACTITIONER; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INSTITUTIONALIZATION; LIFE EXPECTANCY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIINFARCT DEMENTIA; NATIONAL HEALTH SERVICE; PATIENT COMPLIANCE; PATIENT INFORMATION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SOCIAL STATUS; SOCIAL WORK; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL TIME; TELEPHONE; TREATMENT OUTCOME; UNITED KINGDOM;

AGE OF ONSET; AGED; ASPIRIN; DEMENTIA, VASCULAR; FEMALE; HOSPITALIZATION; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037797285     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.857     Document Type: Article

References (21)

1. Antithrombotic Trialists' Collaboration. 2002. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 324(7329): 71-86.
2. Cervilla JM, Prince M, Joels S, et al. 2000. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry 177: 66-71.
3. Dennis M, Boyle A. 1998. Management of cognitive impairment of vascular origin. Psychiatr Bull R Coll Psychiatr 22: 285-287.
4. Forette F, Seux ML, Staessen JA, et al. 1998. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352(9137): 1347-1351.
5. In't Veld BA, Ruitenberg A, Hofman A, et al. 2001. Antihypertensive drugs and incidence of dementia: The Rotterdam Study. Neurobiol Aging 22(3): 407-412.
6. Koopmans RT, Ekkerink JL, Sirre LJ, et al. 1992. [Multi-infarct dementia in nursing home patients; More comorbidity and shorter life expectancy than in Alzheimer's disease.] Ned Tijdschr Geneeskd 136(45): 2223-2227.
7. McGonigal G, McQuade CA, Thomas BM, Whalley LJ. 1992. Survival in pre-senile Alzheimer's and multi-infarct dementias. Neuroepidemiology 11(3): 121-126.
8. Meyer JS, Judd BW, Tawaklna T, et al. 1986. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 256(16): 2203-2209.
9. Meyer JS, Rogers RL, McClintic K, et al. 1989. Randomised clinical trial of daily aspirin therapy in multi-infarct dementia: A pilot study. J Am Geriatr Soc 37(6): 549-555.
10. Meyer JS, Rauch G, Rauch RA, Haque A. 2000. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging 21(2): 161-169.
11. Mölsä PK, Marttila RJ, Rinne UK. 1986. Survival and cause of death in Alzheimer disease and multi-infarct dementia. Acta Neurol Scand 74(2): 103-107.
12. National Intitute for Clinical Excellence. 2001. Guidance on the Use of Donepezil, Rivastigmine and Galantamine for the Treatment of Alzheimer's Disease. NICE Technology Appraisal Guidance - No. 19.
13. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). 2001. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357: 169-175.
14. Ott A, Breteler MM, De Bruyne MC, et al. 1997. Atrial fibrillation and dementia in a population-based study: The Rotterdam Study. Stroke 28(2): 316-321.
15. Ott A, Stolk RP, Van Harskamp F, et al. 1999. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53: 1937-1942.
16. Schmidt R, Schmidt H, Fazekas F. 2000. Vascular risk factors in dementia. J Neurol 247(2): 81-87.
17. Skoog I, Lernfelt B, Landahl S, et al. 1996. 15-year longitudinal study of blood pressure and dementia. Lancet 347(9009): 1141-1145.
18. Skoog I. 1998. Status of risk factors for vascular dementia. Neuroepidemiology 17(1): 2-9.
19. Williams PS, Rands G, Orrel M, Spector A. Aspirin for vascular dementia (Cochrane Review). In The Cochrane Library, Issue 1. Update Software: Oxford, 2003.
20. Wolfson C, Wolfson DB, Asgharian M, et al. for the Clinical Progression of Dementia Study Group. 2001. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344(15): 1111-1116.
21. World Health Organization. 1992. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva.